Intelligent Bio Solutions (INBS) Invested Capital (2019 - 2025)

Intelligent Bio Solutions has reported Invested Capital for 7 years, with the latest figure at $3.0 million in Q2 2025.

• For the quarter ending Q2 2025, Invested Capital fell 63.39% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2025 stood at $3.0 million (down 63.39% YoY), and the FY2025 full-year result was $3.0 million, down 63.39% from the prior year.
• Invested Capital for Q2 2025 stood at $3.0 million, down from $4.9 million in the prior quarter.
• The five-year high for Invested Capital was $15.9 million in Q1 2021, with the low at $1.2 million in Q3 2023.
• Average Invested Capital over 5 years is $7.9 million, with a median of $7.3 million recorded in 2023.
• Year-over-year, Invested Capital jumped 545.28% in 2021 and tumbled 80.1% in 2023.
• Tracing INBS's Invested Capital over 5 years: stood at $10.1 million in 2021, then advanced by 7.23% to $10.8 million in 2022, then slumped by 70.74% to $3.2 million in 2023, then soared by 33.26% to $4.2 million in 2024, then slipped by 28.72% to $3.0 million in 2025.
• The last three Invested Capital figures came in at $3.0 million (Q2 2025), $4.9 million (Q1 2025), and $4.2 million (Q4 2024), per Business Quant data.

Peer Comparison